Cardiovascular revascularization medicine : including molecular interventions
-
Cardiovasc Revasc Med · Oct 2017
Observational StudyFirst experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
We aimed to evaluate efficacy and safety of left atrial appendage (LAA) closure with the new Watchman FLX and analyze procedural features in a consecutive series of high risk non-valvular atrial fibrillation patients. ⋯ We evaluated the efficacy and safety of left atrial appendage (LAA) closure with the new Watchman FLX and analyzed procedural features in a consecutive series of high risk non-valvular atrial fibrillation patients. This is a first observational study demonstrating procedural safety, complete sealing of the LAA and simple technique for repositioning. There was no stroke within a 6month follow-up.